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Objective: This study evaluated the early effectiveness of isolated pectoralis minor tenotomy (PMT) in the surgical
treatment of selected patients with neurogenic thoracic outlet syndrome (NTOS) compared with supraclavicular
decompression (SCD; as scalenectomy, neurolysis, and ﬁrst rib resection) plus PMT (SCDDPMT).
Methods: Data were obtained for 200 patients undergoing operative treatment for disabling NTOS between 2008 and
2011. Isolated PMT was offered to 57 patients with physical examination ﬁndings limited to the subcoracoid space, and
SCDDPMT was offered to 143 with scalene triangle and subcoracoid ﬁndings. Functional outcomes were assessed before
and 3 months after surgery using the Disabilities of the Arm, Shoulder andHand (DASH) survey and related instruments.
Results: There were no signiﬁcant differences (P > .05) between PMT and SCDDPMT patients with respect to age
(overall, 37 ± 1 years), sex (73% women), side affected (52% right, 14% bilateral), or the frequency of various NTOS
symptoms, but fewer PMT patients had a bony anomaly (0% vs 18%; P < .01) or a history of injury (35% vs 61%; P < .01).
Mean preoperative DASH scores were similar between PMT and SCDDPMT groups (49.9 ± 3.6 vs 50.8 ± 1.6), but
previous use of opiate pain medications was higher in PMT patients (47% vs 20%; P[ .0004). PMT was conducted as an
outpatient procedure, whereas the mean hospital stay after SCDDPMT was 4.8 ± 0.1 days, with two patients (1%)
requiring early reoperations for persistent lymph leaks. Mean DASH scores 3 months after surgery were signiﬁcantly
improved after isolated PMT (29.6 ± 4.2; P < .01) and SCDDPMT (41.5 ± 2.2; P < .01), but the mean extent of
improvement in DASH scores was not signiﬁcantly different in PMT (32% ± 9%) vs SCDDPMT (19% ± 5%). There were
also no signiﬁcant differences in the proportion of PMT vs SCDDPMT patients demonstrating improvement in func-
tional outcome measures (75% vs 72%) or in overall use of opiate medications (35% vs 27%).
Conclusions: Isolated PMT is a low-risk outpatient procedure that is effective for the treatment of selected patients with
disabling NTOS, with early outcomes similar to SCDDPMT. These ﬁndings emphasize the importance of recognizing
subcoracoid brachial plexus compression as part of the spectrum of NTOS and support the role of PMT in surgical
management. (J Vasc Surg 2013;57:1345-52.)Neurogenic thoracic outlet syndrome (NTOS) is a
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://dx.doi.org/10.1016/j.jvs.2012.11.045irritation of the brachial plexus nerves within the scalene
triangle at the level of the ﬁrst rib or underneath the pec-
toralis minor muscle tendon in the subcoracoid space.1,2
NTOS most frequently occurs in relatively young, active,
and otherwise healthy individuals, particularly those
engaged in heavy lifting, prolonged use of the upper
extremity, or frequent overhead activity, but may also
develop as a form of repetitive strain injury in the
workplace.3
The symptoms of NTOS are typiﬁed by pain, numbness,
and paresthesia in the neck, arm or hand, or both, with
reproducible exacerbation by elevation of the upper
extremity, along with a consistent constellation of physical
examination ﬁndings.4 NTOS is often associated with
a history of previous neck or upper extremity injury,
previous surgical and nonsurgical treatment approaches
intended to alleviate the presenting symptoms, and pro-
tracted delays in diagnosis. The symptoms of NTOS may
be particularly important because they can progress to
disability in young active persons in the prime of working
life. The role of surgical treatment for NTOS remains some-
what controversial due to variations in diagnosis and1345
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ties, and medical centers.5 The factors determining optimal
outcomes for the surgical treatment of NTOS are therefore
incompletely understood.
Recent studies have highlighted the potential impor-
tance of brachial plexus compression in the subcoracoid
space, underlying the pectoralis minor muscle tendon, as
part of the spectrum of NTOS.6-9 Recognition of this
condition has led to the emergence of pectoralis minor
tenotomy (PMT) as a potential surgical option for selected
patients with NTOS, but how widely this has been applied
in practice is unclear. Indeed, untreated brachial plexus
compression at the level of the pectoralis minor muscle
may be a cause of persistent or recurrent NTOS after
decompression at the level of the scalene triangle alone,
and in some patients, isolated PMT may be sufﬁcient to
effect a substantial improvement in symptoms.6,9 The
purpose of this study was to evaluate the early effectiveness
of isolated PMT in the surgical treatment of NTOS
compared with conventional thoracic outlet decompression
with supraclavicular decompression (SCD; scalenectomy,
neurolysis, and ﬁrst rib resection) combined with PMT.
METHODS
This study was approved by the Human Research
Protection Ofﬁce (HRPO) at Washington University in
St. Louis, Missouri.
Patients. The study population consisted of 200
patients referred to the Washington University Center for
Thoracic Outlet Syndrome at Barnes-Jewish Hospital for
evaluation and surgical treatment of disabling NTOS
between February 2008 and October 2011. Patients with
arterial or venous forms of TOS in the absence of disabling
NTOS were excluded from review. Detailed information
for each patient was obtained from a prospectively main-
tained database and summarized from ofﬁce notes, hospital
records, imaging studies, operative ﬁndings, and records
from treating physicians and therapists.
Initial evaluation. Pretreatment assessment included
the history and physical examination relevant to NTOS
and a review of previous physician and therapist evaluations,
as well as any imaging studies or electrophysiologic tests
that might have been previously performed. The diagnosis
of NTOS was made predominantly by clinical criteria as
previously described, with particular attention to distinguish-
ing patients with tenderness to palpation and reproduction
of symptoms solely on palpation over the supraclavicular
scalene triangle and those who had isolated or concomitant
tenderness and reproduction of symptoms upon palpation
over the infraclavicular subcoracoid space.2,10
Plain chest radiographs, magnetic resonance angiog-
raphy, or computed tomography angiography studies
were performed, as indicated by clinical circumstances, to
identify bony abnormalities and to exclude vascular types
of TOS but were not routinely obtained. Electrophysio-
logic testing (nerve conduction velocities and electromyog-
raphy) was used selectively to exclude the presence of
cervical nerve root or peripheral nerve (median, radial,ulnar) compression syndromes when clinical ﬁndings
were suggestive of these entities but was not used to estab-
lish the diagnosis of NTOS. In selected patients, the
response to image-guided local anesthetic injections into
the anterior scalene muscle and pectoralis minor muscle,
or into the pectoralis minor muscle alone, were used as
an adjunct to the clinical diagnosis and to help predict likely
responsiveness to treatment.
All patients were asked to complete the Disabilities of
the Arm, Shoulder and Hand (QuickDASH) survey instru-
ment, the Cervical-Brachial Symptom Questionnaire
(CBSQ), and a 10-point visual analog scale (VAS) for
pain.11-13 The QuickDASH, an 11-item survey scored on
a 0 to 100 scale, is designed and validated for quantifying
the degree of disability in a variety of upper extremity
musculoskeletal disorders, including NTOS.14-16 The
CBSQ is a 14-item survey scored on a 0 to 120 scale
that was developed for evaluation of patients with NTOS
and related disorders to measure functional disturbances
resulting from the performance of certain activities. The
VAS is a widely used standard method for pain assessment.
The results of these patient-reported instruments were
combined to calculate the NTOS Index (NTOS
Index ¼ [DASH þ {0.83  CBSQ} þ {10  VAS}]/3),
a composite measure scored on a 0 to 100 scale, with
higher numbers indicating a greater degree of disability,
as previously described.16 All patients not previously
treated for NTOS, and those for whom previous physical
therapy did not appear to have been suitably targeted
toward NTOS, underwent a 4- to 6-week course of
NTOS-speciﬁc physical therapy overseen by a therapist
with appropriate experience and expertise.2,17,18
Surgical treatment. Surgical treatment was offered to
patients with a sound clinical diagnosis of NTOS, a substan-
tial level of disability, and absence of signiﬁcant improve-
ment after a course of suitable NTOS-speciﬁc physical
therapy. All patients for whom surgical treatment was
recommended therefore had disabling symptoms that had
been refractory to conservative management. The interval
between initial diagnosis and referral, the types and
outcomes of previous treatment, or the response to ante-
rior scalene muscle/pectoralis minor muscle anesthetic
blocks did not preclude consideration for surgical treat-
ment. Patients with physical examination ﬁndings limited
to the subcoracoid space underwent isolated PMT, whereas
patients with physical examination ﬁndings localized to the
scalene triangle and the subcoracoid space underwent
combined supraclavicular decompression (SCD) and PMT
(SCDþPMT).
Isolated PMT was performed with the patient under
general anesthesia through a vertical infraclavicular incision
in the deltopectoral groove.19 The lateral edge of the pec-
toralis major muscle was lifted, and the underlying pector-
alis minor muscle was exposed. The pectoralis minor
tendon was encircled just below its insertion onto the cora-
coid process, without further dissection of the underlying
neurovascular structures, and separated from the adjacent
tendon of the short head of the biceps. The pectoralis
Table I. Characteristics of the study population
Variablea
Isolated
PMT
(n ¼ 57)
SCDþPMT
(n ¼ 143) Pb
Age, years 37 6 2 37 6 1 NS
Female sex 40 (70) 106 (74) NS
Bony anomaly
(eg, cervical rib)
0 (0) 26 (18) <.001
History of injury 20 (35) 87 (61) .0016
Repetitive motion 4 (7) 24 (17) NS
Motor vehicle
collision
6 (10) 29 (20) NS
Fall on arm 7 (12) 30 (21) NS
Other 3 (5) 13 (9) NS
NS, Not signiﬁcant; PMT, pectoralis minor tenotomy; SCD, supraclavicular
decompression.
aContinuous data are shown as the mean 6 standard error of the mean and
categoric data as number (%).
bComparison between isolated PMT and SCDþPMT groups by unpaired
two-tailed t-test with Welch correction (for continuous data) or Fisher
exact test (for categoric data); values of P > .05 are indicated as NS.
Table II. Frequency of patient-reported symptoms
Variable
Isolated PMT,
No. (%)
SCDþPMT,
No. (%) Pa
Shoulder pain 54/54 (100) 131/141 (93) NS
Neck pain 43/54 (80) 128/141 (91) .0494
Arm weakness 49/54 (91) 132/141 (94) NS
Arm pain 47/54 (87) 128/141 (91) NS
Arm heaviness 40/54 (74) 117/141 (83) NS
Hand weakness 43/54 (80) 126/141 (89) NS
Hand pain 41/54 (76) 120/141 (85) NS
Numbness/tingling
Hand 50/54 (93) 127/140 (91) NS
Arm 46/54 (85) 123/141 (87) NS
Waking up at night 40/54 (74) 122/141 (86) NS
Trouble getting to
sleep
39/54 (72) 104/141 (74) NS
Muscle spasm
Neck 31/54 (57) 85/141 (60) NS
Arm 31/54 (57) 70/141 (50) NS
Cold feeling
Hand 30/54 (56) 94/140 (67) NS
Arm 24/54 (44) 78/141 (55) NS
Headaches
Occipital 29/54 (54) 78/141 (55) NS
Front of head 25/53 (47) 76/141 (54) NS
Back pain 29/54 (54) 106/141 (75) .0053
Cramping episodes
in hand
29/54 (54) 89/141 (63) NS
Too sleepy during
the day
28/54 (52) 106/140 (76) .0018
Shortness of breath
On exertion 27/53 (51) 63/141 (45) NS
At rest 14/53 (26) 38/141 (27) NS
Hand swelling 23/54 (43) 69/141 (49) NS
Back muscle spasm 21/54 (39) 64/141 (45) NS
Fingers change colors 20/54 (37) 63/141 (45) NS
Hard area or lump,
neck
17/54 (31) 56/141 (40) NS
Vision changes 16/54 (30) 41/141 (29) NS
Bluish discoloration
Hand 15/53 (28) 50/141 (35) NS
Arm 7/53 (13) 26/141 (18) NS
Arm swelling 15/54 (28) 50/141 (35) NS
Pain in the side on
exertion
15/54 (28) 58/141 (41) NS
Neck swelling 13/54 (24) 51/141 (36) NS
Enlarged veins
Arm 7/52 (13) 29/141 (21) NS
Shoulder 7/52 (13) 26/141 (18) NS
Excessive sweating
Hand 7/54 (13) 37/141 (26) NS
Face 6/54 (11) 24/141 (17) NS
Drooping eyelid 6/54 (11) 17/141 (12) NS
NS, Not signiﬁcant; PMT, pectoralis minor tenotomy; SCD, supraclavicular
decompression.
aComparison between isolated PMT and SCDþPMT groups, Fisher
exact test (for categoric data); values of P > .05 are indicated as NS.
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edge of the muscle was oversewn for hemostasis. In
patients with bilateral symptoms, a contralateral PMT was
also performed in the same operation. All PMTs were per-
formed as same-day outpatient procedures.
SCD was performed under general anesthesia as
described.16 After mobilization of the scalene fat pad, the
procedure included complete anterior and middle scalenec-
tomy, resection of any aberrant ﬁbromuscular bands, mobi-
lization and protection of the brachial plexus with external
neurolysis of the ﬁve nerve roots (C5-T1), and ﬁrst rib
resection.20,21 If a partial or complete cervical rib was
present, it was also entirely resected. PMT was performed
in conjunction with SCD after the supraclavicular portion
of the operation had been completed.
Postoperative follow-up. Postoperative physical ther-
apy was begun the day after surgical treatment to maintain
neck and upper extremity range of motion and to minimize
muscle spasm. Opiate pain medications, a muscle relaxant,
and an anti-inﬂammatory agent were routinely adminis-
tered. In the absence of complications, patients undergoing
SCDþPMT were discharged from the hospital when
adequate pain control had been achieved solely on oral
medications, there was no nausea or constipation accom-
panying opiate use, the patient could comfortably perform
physical therapy, and there was low daily output from the
closed-suction drain. The closed-suction surgical drain was
removed during an outpatient visit during the ﬁrst week
after operation.
Postoperative physical therapy was continued on
a regular schedule until 12 weeks, when unrestricted upper
extremity activity was permitted and discontinuation of
opiate medications encouraged. Clinical follow-up 3
months after operation included physical therapy evalua-
tion, review of medications, and completion of patient-
reported functional outcomes assessment instruments.Data analysis. The principal outcomes evaluated were
functional measures as assessed by the DASH, CBSQ,
VAS, and NTOS Index, including proportionate changes
between preoperative and postoperative status, and patient
use of opiate pain medications. Descriptive group data are
presented as the mean 6 standard error of the mean or the
median and range of values. These end points were
Fig 1. Bar graphs indicate the side of operation and operative distribution in 200 patients undergoing surgical
treatment for neurogenic thoracic outlet syndrome by isolated pectoralis minor tenotomy (PMT) or supraclavicular
decompression with PMT.
Table III. Preoperative functional assessment measures
and use of opiate medications
Variable
Isolated PMT, SCDþPMT,
Pa
mean 6 SEM
(No.)
mean 6 SEM
(No.)
Functional
assessment
DASH score 49.9 6 3.6 (48) 50.8 6 1.6 (137) NS
CBSQ score 62.7 6 4.3 (43) 76.1 6 2.3 (128) .0079
VAS pain score 6.1 6 0.3 (44) 7.2 6 0.6 (123) NS
NTOS Indexb 54.5 6 3.4 (35) 62.7 6 2.3 (113) NS
No. (%) No. (%)
Opiate pain
medication use
Any opiates 27 (47) 29 (20) .0004
Moderatec 16 (28) 18 (13) .0121
Strongd 6 (10) 8 (6) NS
Moderate þ strong 5 (9) 3 (2) .0437
CBSQ, Cervical-Brachial Symptom Questionnaire; DASH, Disabilities of
the Arm, Shoulder, and Hand; NS, not signiﬁcant; NTOS, neurogenic
thoracic outlet syndrome; PMT, pectoralis minor tenotomy; SCD, supra-
clavicular decompression; SEM, standard error of the mean; VAS, visual
analog scale.
aComparison between isolated PMT and SCDþPMT groups, unpaired
two-tailed t-test with Welch correction or Fisher exact test for categoric
data; values of P > .05 are indicated as NS.
bComposite measure combining the DASH, CBSQ, and VAS pain scores.
cU.S. Drug Enforcement Administration Schedule III and IV narcotic
mediations.
dU.S. Drug Enforcement Administration Schedule II narcotic medications.
JOURNAL OF VASCULAR SURGERY
1348 Vemuri et al May 2013evaluated to compare the isolated PMT and the
SCDþPMT groups using the unpaired t-test with Welch
correction (for data with continuous variables) or the
Fisher exact test (for categoric data). Statistical tests were
performed using Prism 4.0c software (GraphPad Software
Inc, La Jolla, Calif), with P < .05 considered signiﬁcant.
RESULTS
Patient population and preoperative characteris-
tics. There were 200 patients who met the study criteria,
including 57 (28%) who underwent isolated PMT and
143 (72%) who underwent SCDþPMT. As summarized
in Table I, there were 54 men (27%) and 146 women
(73%), with an overall mean age at the time of treatment of
37 6 1 years (median, 39; range, 12-76 years). The PMT
and the SCDþPMT groups did not differ signiﬁcantly with
respect to age and sex, but fewer PMT patients had bony
anomalies (0% vs 18%; P < .01) and a history of injury (35%
vs 61%; P < .01) than SCDþPMT patients (Table I). A
survey of 38 different clinical features potentially associated
with NTOS (Table II) showed the overall frequency and
extent of symptoms were similar between groups, with
signiﬁcant difference noted only for neck pain (PMT, 80%;
SCDþPMT, 90%), back pain (PMT, 54%; SCDþPMT,
75%), and daytime sleepiness (PMT, 52%; SCDþPMT,
76%). The PMT and SCDþPMT patients did not differ
signiﬁcantly with respect to the primary side affected
(overall, 54% right) or the presence of bilateral symptoms
(overall, 14%; Fig 1).
Functional assessment measures did not differ signiﬁ-
cantly between the groups for the mean preoperative
DASH scores and VAS pain ratings, but the mean CBSQ
scores were lower in the PMT group (Table III). The
mean preoperative NTOS Index (a composite of the
DASH, CBSQ and VAS scores) was not signiﬁcantly
different between the PMT and the SCDþPMT groups(Table III). As reported in Table III, 56 of 200 patients
(28%) used opiate pain medications before surgical treat-
ment, including 34 (17%) using moderate opiates, 14
(7%) using strong opiates, and eight (4%) using
moderate and strong opiates. The overall frequency of
Table IV. Functional assessment measures and use of
opiate medications at 3 months
Variable
Isolated PMT, SCDþPMT,
Pa
mean 6 SEM
(No.)
mean 6 SEM
(No.)
Functional
assessment
DASH score 29.6 6 4.2 (35) 41.5 6 2.2 (105) .0151
CBSQ score 38.8 6 5.7 (32) 44.0 6 3.3 (102) NS
VAS pain score 4.2 6 0.4 (31) 4.4 6 0.3 (93) NS
NTOS Indexb 36.8 6 3.8 (26) 41.3 6 2.5 (84) NS
No. (%) No. (%)
Opiate pain
medication use
Any opiates 20 (35) 39 (27) NS
Moderatec 12 (21) 2 (1) <.0001
Strongd 7 (12) 31 (22) NS
Moderate þ strong 1 (2) 6 (4) NS
CBSQ, Cervical-Brachial Symptom Questionnaire; DASH, Disabilities of
the Arm, Shoulder, and Hand;NS, not signiﬁcant;NTOS, neurogenic thoracic
outlet syndrome; PMT, pectoralis minor tenotomy; SCD, supraclavicular
decompression; SEM, standard error of the mean; VAS, visual analog scale.
aComparison between isolated PMT and SCDþPMT groups, unpaired
two-tailed t-test with Welch correction or Fisher exact test for categoric
data; values of P > .05 are indicated as NS.
bComposite measure combining the DASH, CBSQ, and VAS pain scores.
cU.S. Drug Enforcement Administration Schedule III and IV narcotic
mediations.
dU.S. Drug Enforcement Administration Schedule II narcotic medications.
Fig 2. Individual patient responses to treatment are shown in line graphs depicting Disabilities of Arm, Shoulder and
Hand (DASH) scores for patients with neurogenic thoracic outlet syndrome before surgery and at the 3-month follow-
up after (left) isolated pectoralis minor tenotomy (PMT) and (right) supraclavicular decompression (SCD)þPMT. The
red line indicates the mean values for each group.
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PMT group than in the SCDþPMT group (47% vs 20%;
P < .0004).
Surgical treatment. The surgical treatment was
successful in all patients, with no intraoperative complica-
tions. The isolated PMT procedures were all performed
as short same-day outpatient operations, whereas the
mean inpatient hospital stay after SCDþPMT was 4.8 6
0.1 days. There were no postoperative complications
requiring reoperation in the PMT group, but two patients(1%) required an early reoperation for persistent lymph
leaks after SCDþPMT.
Postoperative outcomes. Most patients undergoing
surgical treatment for NTOS exhibited signiﬁcant and
progressive improvement in symptoms by the 3-month
follow-up interval, comprising 163 of 200 patients (81%)
overall, 43 of 57 (75%) after isolated PMT, and 120 of 143
(84%) after combined SCDþPMT. Similarly, the response
of individual patients to treatment exhibited a trend toward
signiﬁcant improvement at 3 months for the isolated PMT
and SCDþPMT groups, with a small number of outliers in
each group that did not improve (Fig 2). Although mean
DASH scores at 3 months were signiﬁcantly lower for the
isolated PMT patients than for the SCDþPMT group
(29.6 6 4.2 vs 41.5 6 2.2; P ¼ .0151), there were no
differences between groups with respect to mean CBSQ,
VAS, or NTOS Index scores (Table IV). There were also
no differences between groups with respect to the overall
proportion of patients taking opiate pain medications
(PMT, 35%; SCDþPMT, 27%), although patients in the
isolated PMT group had more frequent use of moderate
opiates than those in the SCDþPMT group (Table IV).
As shown in Fig 3, the overall extent of improvement
in the four functional outcome measures at the 3-month
follow-up ranged from 13% to 34% in the PMT group
and from 19% to 34% in the SCDþPMT group. Even at
this relatively early interval, the overall percentage of
patients exhibiting improvement in functional outcome
scores was 64% to 87% (PMT group) and 71% to 83%
(SCDþPMT group). These analyses indicated that the
measured extent of improvement was similar between
patients undergoing isolated PMT and SCDþPMT.
DISCUSSION
Brachial plexus compression in NTOS may occur
at the level of the supraclavicular scalene triangle, the infra-
clavicular subcoracoid space, or in both locations. It has
been recently emphasized that nerve compression at the
level of the pectoralis minor tendon can make a substantial
contribution to symptoms and, in many cases, may
Fig 3. Bar graphs depict the extent of postoperative improvement and functional outcome, as assessed by the
Disabilities of the Arm, Shoulder, and Hand (DASH), Cervical-Brachial Symptom Questionnaire (CBSQ), visual analog
scale (VAS), and neurogenic thoracic outlet syndrome (NTOS) Index (composite measure combining the DASH,
CBSQ, and VAS pain scores), at 3 months after surgical treatment for NTOS by isolated pectoralis minor tenotomy
(PMT) or supraclavicular decompression (SCD)þPMT. The plotted values represent the mean 6 standard error of the
mean (error bars), and the inset values depict the overall percentage of patients exhibiting improvement. There were no
signiﬁcant differences (P > .05) between groups for any of the four functional outcome measures (comparisons
between isolated PMT and SCDþPMT groups, unpaired two-tailed t-test with Welch correction).
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triangle.7,8 Recognition and treatment of this potential site
of nerve compression is therefore important in the manage-
ment of NTOS. Furthermore, untreated brachial plexus
compression at the pectoralis minor may be an important
factor in persistent or recurrent symptoms after operations
for NTOS and may explain a proportion of surgical failures
in previous clinical series.6,9 It is also increasingly apparent
that some patients with NTOS exhibit brachial plexus
compression predominantly at the level of the pectoralis
minor muscle. For these individuals, isolated PMT may
provide a minimally invasive surgical option associated
with rapid postoperative recovery and a high likelihood of
clinical success.8 Understanding the role of this condition
has therefore been an important step in our evolving
knowledge of NTOS.
In the present study, we demonstrated that selected
patients with disabling NTOS can improve substantially
after surgical treatment by isolated PMT, as well as by
more conventional SCDþPMT, compared with their
condition before the operation. Although the patients in
this study were comparable with respect to the clinical
presentation of NTOS and failure to improve with conser-
vative treatment, those with physical examination ﬁndings
conﬁned to the subcoracoid space were offered surgical
treatment by isolated PMT. The symptoms most
frequently suggesting pectoralis minor compression
included infraclavicular, anterior chest wall, or axillary
pain, but the nature of upper extremity symptoms and
the response to upper extremity positional maneuvers was
similar to that of patients with brachial plexus compression
at the scalene triangle.8 One valuable and potentiallyspeciﬁc physical examination maneuver that we used was
tenderness and reproduction of upper extremity symptoms
during direct palpation over the subcoracoid space, with at
least partial resolution of symptoms when the patient
simultaneously contracted the pectoralis major muscle,
which prevented transmission of digital pressure to the
underlying pectoralis minor muscle and neurovascular
bundle.19 This experience thereby helps to identify clinical
factors that may be associated with NTOS potentially
amenable to treatment by isolated PMT.
We used several patient-reported survey instruments to
assess preoperative characteristics of individuals with NTOS
and to provide quantiﬁable outcome measures of treatment
results.16 Before treatment, therewas no signiﬁcant difference
in mean scores for the DASH, VAS, and NTOS Index
between patients in the PMT group and those in the
SCDþPMT group, although the mean CBSQ score was
signiﬁcantly lower in the PMT group. The results of using
thesemeasures, aswell as descriptive evaluationsof symptoms,
showed that PMT and SCDþPMT patients both exhibited
signiﬁcant improvement 3 months after surgical treatment,
but the extent of improvement was not measurably different
between groups. These ﬁndings conﬁrm that isolated PMT
is successful in treating disabling NTOS with physical exami-
nation ﬁndings conﬁned to the subcoracoid space. Given that
this was accomplished with a short, low-risk, outpatient oper-
ation compared with SCDþPMT, our results suggest that an
evaluation for potential responsiveness to isolated PMT
should be a high priority in the management of patients
with NTOS considering surgical treatment.
Some of the strengths of this study include a relatively
large number of patients with NTOS and the consistency
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with protocol-driven care provided through the operating
room, inpatient hospital stay, and postoperative phases of
care.
Study limitations include its retrospective nature and the
absence of a cohort solely managed conservatively for
NTOS.We also did not regularly use quality-of-lifemeasures
in the interval during which these patients were treated.
Another important limitation is the relatively short-term
follow-up, in which we evaluated early postoperative results
but do not yet have information on long-term outcomes. It
is well recognized that patients with NTOS may exhibit
improvement early in follow-up after surgical treatment
but may have residual or recurrent symptoms at later inter-
vals. This may be especially relevant because recurrent symp-
toms of NTOS appear to arise predominantly within the ﬁrst
2 years after surgical treatment, such that the duration of
follow-up reported here may not have taken into account
the potential development of recurrent NTOS or the need
for reoperative procedures at later intervals.6,22 Additional
investigations will therefore be needed to further delineate
the optimal role and outcomes achieved for treatment of
NTOS with isolated PMT.
CONCLUSIONS
PMT is indicated for patients with disabling NTOS
who have not had a satisfactory response to appropriately
targeted physical therapy and in whom the physical exam-
ination reveals signiﬁcant tenderness and reproduction of
upper extremity neurogenic symptoms upon palpation
over the subcoracoid space. Physical examination helps to
distinguish patients with brachial plexus nerve compression
conﬁned to the level of the pectoralis minor muscle, in
whom isolated PMT may be considered. Isolated PMT is
a low-risk outpatient procedure effective for the treatment
of selected patients with disabling NTOS, with short-term
outcomes similar to if not better than SCDþPMT. The
ﬁndings of this study emphasize the importance of recog-
nizing subcoracoid brachial plexus compression as part of
the spectrum of NTOS and support the role of PMT in
surgical management.
We are grateful to the referring physicians who allowed
us to participate in the care of their patients and are
indebted to Verdella Brink, Yvette Blakemore, and Robert
Fuller, RMA, for their help in caring for our patients with
thoracic outlet syndrome.
AUTHOR CONTRIBUTIONS
Conception and design: CV, AW, JE, MD, RR, VE, RT
Analysis and interpretation: CV, AW, FC, VE, RT
Data collection: CV, AW, FC, VE, RT
Writing the article: CV, AW, FC, RT
Critical revision of the article: CV, AW, FC, JE, MD, RR,
VE, RT
Final approval of the article: CV, AW, FC, JE, MD, RR,
VE, RT
Statistical analysis: CV, AW, RTObtained funding: RT
Overall responsibility: RT
REFERENCES
1. Sanders RJ, Hammond SL, Rao NM. Thoracic outlet syndrome:
a review. Neurologist 2008;14:365-73.
2. Thompson RW, Driskill M. Thoracic outlet syndrome: neurogenic. In:
Cronenwett JL, Johnston KW, editors. Rutherford’s vascular surgery.
7th ed. Philadelphia, PA: Elsevier; 2010. p. 1878-98.
3. Pascarelli EF, Hsu YP. Understanding work-related upper extremity
disorders: clinical ﬁndings in 485 computer users, musicians, and
others. J Occup Rehabil 2001;11:1-21.
4. Sanders RJ, Hammond SL, Rao NM. Diagnosis of thoracic outlet
syndrome. J Vasc Surg 2007;46:601-4.
5. Mackinnon SE, Novak CB. Thoracic outlet syndrome. Curr Probl Surg
2002;39:1070-145.
6. Ambrad-Chalela E, Thomas GI, Johansen KH. Recurrent neurogenic
thoracic outlet syndrome. Am J Surg 2004;187:505-10.
7. Sanders RJ. Pectoralis minor syndrome. In: Eskandari MK,
Morasch MD, Pearce WH, Yao JST, editors. Vascular surgery: thera-
peutic strategies. Shelton, CT: People’s Medical Publishing House-
USA; 2010. p. 149-60.
8. Sanders RJ, Rao NM. The forgotten pectoralis minor syndrome: 100
operations for pectoralis minor syndrome alone or accompanied by
neurogenic thoracic outlet syndrome. Ann Vasc Surg 2010;24:701-8.
9. Sanders RJ. Recurrent neurogenic thoracic outlet syndrome stressing
the importance of pectoralis minor syndrome. Vasc Endovascular Surg
2011;45:33-8.
10. Emery VB, Rastogi R, Driskill MR, Thompson RW. Diagnosis of neuro-
genic thoracic outlet syndrome. In: Eskandari MK, Morasch MD,
Pearce WH, Yao JST, editors. Vascular surgery: therapeutic strategies.
Shelton, CT: People’s Medical PublishingHouse-USA; 2010. p. 129-48.
11. Beaton DE, Katz JN, Fossel AH, Wright JG, Tarasuk V,
Bombardier C. Measuring the whole or the parts? Validity, reliability,
and responsiveness of the Disabilities of the Arm, Shoulder and Hand
outcome measure in different regions of the upper extremity. J Hand
Ther 2001;14:128-46.
12. Gummesson C, Atroshi I, Ekdahl C. The disabilities of the arm,
shoulder and hand (DASH) outcome questionnaire: longitudinal
construct validity and measuring self-rated health change after surgery.
BMC Musculoskelet Disord 2003;4:11.
13. Jordan SE, Ahn SS, Gelabert HA. Differentiation of thoracic outlet
syndrome from treatment-resistant cervical brachial pain syndromes:
development and utilization of a questionnaire, clinical examination
and ultrasound evaluation. Pain Physician 2007;10:441-52.
14. Chang DC, Rotellini-Coltvet L, Mukherjee D, DeLeon R,
Freischlag JA. Surgical intervention for thoracic outlet syndrome
improves patients’ quality of life. J Vasc Surg 2009;49:630-5.
15. Chandra V, Olcott Ct, Lee JT. Early results of a highly selective
algorithm for surgery on patients with neurogenic thoracic outlet
syndrome. J Vasc Surg 2011;54:1698-705.
16. Caputo FJ, Wittenberg AM, Vemuri C, Driskill MR, Earley JA,
Rastogi R, et al. Emery VB, Thompson RW. Supraclavicular decom-
pression for neurogenic thoracic outlet syndrome in adolescent and
adult populations. J Vasc Surg 2012 [Epub ahead of print] doi: 10.
1016/j.jvs.2012.07.025.
17. Novak CB. Conservative management of thoracic outlet syndrome.
Semin Thorac Cardiovasc Surg 1996;8:201-7.
18. Edgelow P. Neurovascular consequences of cumulative trauma disor-
ders affecting the thoracic outlet: a patient centered treatment
approach. In: Donatelli R, editor. Physical therapy of the shoulder.
New York: Churchill Livingston; 2004. p. 205-38.
19. Thompson RW. Pectoralis minor tenotomy for neurogenic thoracic
outlet syndrome. In: Illig KA, Thompson RW, Feischlag JA,
Donahue DM, Jordan SE, Edgelow PI, editors. Thoracic outlet
syndrome. London: Springer; 2013.
20. Thompson RW, Petrinec D, Toursarkissian B. Surgical treatment of
thoracic outlet compression syndromes. II. Supraclavicular exploration
and vascular reconstruction. Ann Vasc Surg 1997;11:442-51.
JOURNAL OF VASCULAR SURGERY
1352 Vemuri et al May 201321. Melby SJ, Thompson RW. Supraclavicular (paraclavicular)
approach for thoracic outlet syndrome. In: Pearce WH,
Matsumura JS, Yao JST, editors. Operative vascular surgery in the
endovascular era. Evanston: Greenwood Academic; 2008. p.
434-45.22. Altobelli GG, Kudo T, Haas BT, Chandra FA, Moy JL, Ahn SS.
Thoracic outlet syndrome: pattern of clinical success after operative
decompression. J Vasc Surg 2005;42:122-8.
Submitted Sep 6, 2012; accepted Nov 8, 2012.
